Log in to save to my catalogue

Genetic inactivation of zinc transporter SLC39A5 improves liver function and hyperglycemia in obesog...

Genetic inactivation of zinc transporter SLC39A5 improves liver function and hyperglycemia in obesog...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4cfb8adbbf2e476a8a97ea22b5553ed1

Genetic inactivation of zinc transporter SLC39A5 improves liver function and hyperglycemia in obesogenic settings

About this item

Publication information

Publisher

England: eLife Science Publications, Ltd

More information

Scope and Contents

Contents

Recent studies have revealed a role for zinc in insulin secretion and glucose homeostasis. Randomized placebo-controlled zinc supplementation trials have demonstrated improved glycemic traits in patients with type II diabetes (T2D). Moreover, rare loss-of-function variants in the zinc efflux transporter
SLC30A8
reduce T2D risk. Despite this a...

Alternative Titles

Full title

Genetic inactivation of zinc transporter SLC39A5 improves liver function and hyperglycemia in obesogenic settings

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_4cfb8adbbf2e476a8a97ea22b5553ed1

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4cfb8adbbf2e476a8a97ea22b5553ed1

Other Identifiers

ISSN

2050-084X

E-ISSN

2050-084X

DOI

10.7554/eLife.90419

How to access this item